NLRP3 inflammasome and autophagy pathways synergistically drive cytokine storm and severe dengue.
Background
Dengue infection, affecting 350 million globally, ranges from mild febrile illness to severe, life-threatening forms characterized by vascular leakage. While dysregulated immune responses are known drivers of progression, the precise roles of NLRP3 inflammasome activation and autophagy in Dengue pathogenesis, particularly in driving the cytokine storm and vascular leakage, have remained unclear. Understanding these pathways is crucial for identifying novel therapeutic targets to mitigate severe disease outcomes.
Study Design
Researchers enrolled 318 confirmed Dengue patients (n=229 with dengue fever ± warning signs; n=89 with severe dengue) and 50 healthy controls. Peripheral blood mononuclear cells (PBMCs) were analyzed for inflammasome (NLRP3, RIG1) and autophagy (Beclin1, LC3B) gene expression via qRT-PCR, and cytokine levels (IL-1β, IL-18) in sera and stimulated PBMCs by ELISA. Protein expression of Beclin1 and LC3B was assessed by Western blot. In vitro, PBMCs were stimulated with dengue peptide pools, subjected to NLRP3 siRNA silencing, and treated with rapamycin (autophagy inducer) or 3-methyladenine (autophagy inhibitor) to modulate pathways.
Results
In Dengue patients, NLRP3, RIG1, and associated inflammasome genes, alongside autophagy markers Beclin1 and LC3B, were significantly upregulated, with the highest expression observed in severe cases. Elevated IL-1β and IL-18 levels in patient sera and stimulated PBMCs correlated positively with NLRP3 expression. Mechanistically, NLRP3 silencing in vitro reduced pro-inflammatory cytokine secretion, highlighting its direct role. Conversely, treatment with rapamycin (an autophagy inducer) enhanced Beclin-1/LC3B expression and cytokine production, while 3-methyladenine (an autophagy inhibitor) suppressed these effects. This suggests a synergistic interplay.
Upregulated
NLRP3inflammasome andBeclin1/LC3Bautophagy pathways in the host may potentially drive hyperinflammatory responses, contributing to vascular leakage in severe Dengue.
Key Findings
NLRP3,RIG1,Beclin1, andLC3Bgenes were significantly upregulated in Dengue patients, peaking in severe cases.- Elevated
IL-1βandIL-18levels in patient sera and PBMCs positively correlated withNLRP3expression. NLRP3silencing in vitro reduced pro-inflammatory cytokine secretion.- Rapamycin (autophagy inducer) enhanced
Beclin-1/LC3Bexpression and cytokine production. - 3-methyladenine (autophagy inhibitor) suppressed
Beclin-1/LC3Bexpression and cytokine production.
Why It Matters
This study provides crucial mechanistic insights into Dengue pathogenesis, identifying the NLRP3 inflammasome and autophagy as key drivers of the cytokine storm and disease severity. Targeting these pathways could offer novel therapeutic strategies for severe Dengue. For biohackers and clinicians, this suggests that interventions modulating NLRP3 or autophagy (e.g., specific autophagy inducers/inhibitors) might be explored to mitigate hyperinflammation. While direct clinical protocols are not yet available, these findings lay the groundwork for developing new anti-inflammatory or immunomodulatory treatments, potentially moving beyond symptomatic care to address the underlying immune dysregulation in severe Dengue.
dengue
nrlp3
inflammasome
autophagy
cytokine-storm
il-1b